Eocene (EOCN) vs Onconetix (ONCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Eocene is the larger company by market cap ($3.9 million vs $3.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EOCN | ONCO |
|---|---|---|
| Share price | $3.62 | $0.6543 |
| Market cap | $3.87M | $3.43M |
| 1-day change | +4.69% | +9.56% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-15.21 | $310.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.80 | $207.00 |
| 52-week low | $3.12 | $0.58 |
| Distance from 52-week high | -71.72% | -99.68% |
| Analyst consensus | none | — |
| Average volume | 59.85K | 2.96M |
| Shares outstanding | 1.07M | 5.24M |
| Employees | 3 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eocene
EOCN stock →Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
EOCN vs ONCO FAQ
Which is bigger, Eocene or Onconetix?
Eocene (EOCN) is larger, with a market capitalization of $3.87M compared with $3.43M for Onconetix (ONCO).
Are Eocene and Onconetix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.